Skip to content
Open access · CC-BY via OpenAlex

Epigenetic and biological age acceleration in children with atopic dermatitis

Richie Jeremian, Alexandra Malinowski, Edward Saehong Oh, Melinda Gooderham, Cathryn J. Sibbald, Jensen Yeung, Yuka Asai, Vincent Piguet, Carolyn S. Jack

Journal of Allergy and Clinical Immunology Global · 2024 · ▲ 6 citations

Abstract

Background Atopic dermatitis (AD) is a chronic inflammatory skin disease resulting from the complex interplay of genetic and environmental factors, meriting exploration using temporally dynamic biomarkers. DNA methylation–based algorithms have been trained to accurately estimate biological age, and deviation of predicted age from true age (epigenetic age acceleration) has been implicated in several inflammatory diseases, including asthma. Objective We sought to determine the role of epigenetic and biological aging, telomere(definition) length, and epigenetically inferred abundance of 7 inflammatory biomarkers in AD. Methods We performed DNA methylation–based analyses in a pediatric AD cohort (n = 24, mean ± standard deviation [SD] age 2.56 ± 0.28 years) and age-matched healthy subjects (n = 24, age 2.09 [0.15] years) derived from blood using 5 validated algorithms that assess epigenetic age (Horvath, Skin&Blood) and biological age (PhenoAge, GrimAge), telomere length (TelomereLength), and inflammatory biomarker levels. Results Epigenetic and biological age, but not telomere length, were accelerated in AD patients for 4 algorithms: Horvath (+0.88 years; 95% confidence interval [CI], 0.33 to 1.4; P = 2.3 × 10 −3 ), Skin&Blood (+0.95 years; 95% CI, 0.67 to 1.2; P = 1.8 × 10 −8 ), PhenoAge (+8.2 years; 95% CI, 3.4 to 13.0; P = 1.3 × 10 −3 ), and GrimAge (+1.8 years 95% CI, 0.22 to 3.3; P = .026). Moreover, patients had increased levels of β 2 microglobulin (+47,584.4 ng/mL; P = .029), plasminogen activation inhibitor 1 (+3,432.9 ng/mL; P = 1.1 × 10 −5 ), and cystatin C (+31,691 ng/mL; P = 4.0 × 10 −5 ), while levels of tissue inhibitor metalloproteinase 1 (−370.7 ng/mL; P = 7.5 × 10 −4 ) were decreased compared to healthy subjects. Conclusion DNA methylation changes associated with epigenetic and biological aging, and inflammatory proteins appear early in life in pediatric AD and may be relevant clinical biomarkers of pathophysiology.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1016/j.jacig.2024.100275
Canonical
link ↗
Fetched
2026-10-16 MST

Cite this

APA
Jeremian, R., Malinowski, A., Oh, E.S., Gooderham, M., Sibbald, C.J., Yeung, J., Asai, Y., Piguet, V., &amp; Jack, C.S. (2024). Epigenetic and biological age acceleration in children with atopic dermatitis. <em>Journal of Allergy and Clinical Immunology Global</em>. https://doi.org/10.1016/j.jacig.2024.100275
Vancouver
Jeremian R, Malinowski A, Oh ES, Gooderham M, Sibbald CJ, Yeung J, et al. Epigenetic and biological age acceleration in children with atopic dermatitis. Journal of Allergy and Clinical Immunology Global. 2024. doi:10.1016/j.jacig.2024.100275.
BibTeX
@article{richie2024Epigen, title = {Epigenetic and biological age acceleration in children with atopic dermatitis}, author = {Richie Jeremian and Alexandra Malinowski and Edward Saehong Oh and Melinda Gooderham and Cathryn J. Sibbald and Jensen Yeung and Yuka Asai and Vincent Piguet and Carolyn S. Jack}, journal = {Journal of Allergy and Clinical Immunology Global}, year = {2024}, doi = {10.1016/j.jacig.2024.100275}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings